{
  "code": "300146",
  "name": "汤臣倍健",
  "market": "A",
  "industry": "行业待核验",
  "quality_tier": "rejected",
  "quality_conflict": false,
  "in_quality_pool": false,
  "quality_source": "2026-10-02-rating-v2；保留原深研评分/判断，修正档位归类",
  "score": 2,
  "verdict": "回避：在扣非利润、现金转化和渠道投入回报得到验证前，不以低PB和较高历史股息率作为买入理由。",
  "dupont": {
    "margin": null,
    "turnover": null,
    "leverage": 1.2289541600098317,
    "roe": 0.059496675191815854,
    "margin_turnover_proxy": 0.04841244460358056,
    "method": "panel_residual_v1",
    "three_factors_complete": false,
    "basis": "面板近似口径：ROE与期末权益乘数；营收缺失，不能独立拆净利率/周转率",
    "conclusion": "面板近似口径：ROE 5.95%，权益乘数 1.23倍；净利率×周转率代数残差 4.84%。ROE日期 2026-08-31，负债率报表期 2026-06-30；缺营收，三因子未完整拆分，残差不代表独立测得ROA。",
    "roe_date": "2026-08-31",
    "leverage_report_date": "2026-06-30",
    "leverage_avail_date": "2026-08-31",
    "inputs": {
      "roe_ttm": 0.059496675191815854,
      "debt_to_assets": 0.1863,
      "net_profit_ttm": 648000000.0,
      "equity": 10891364902.506964,
      "reported_roa_ttm": 0.04841244460358056
    },
    "formulas": {
      "leverage": "1 / (1 - debt_to_assets)",
      "margin_turnover_proxy": "roe_ttm / leverage = roe_ttm * (1 - debt_to_assets)"
    },
    "sources": {
      "roe": "fundamentals_monthly.parquet:roe_ttm",
      "leverage": "ths_ttm_panel.parquet:debt（资产负债率，不是金额）"
    },
    "limitations": [
      "本地面板单源，非独立双源核验。",
      "ROE与负债率可能跨报告期；期末合并权益乘数不等于平均归母权益乘数，少数权益/财务公司/金融企业尤其需复核。",
      "净利润与权益不能反推出营收；净利率、资产周转率保持空值，不假设周转率为1。",
      "代数残差由ROE倒推，不能用乘积相等证明杜邦三因子独立成立。"
    ]
  },
  "roe_series": [
    {
      "year": 2019,
      "roe": 0.2207185628742515,
      "basis": "August TTM"
    },
    {
      "year": 2020,
      "roe": 0.2152195608782435,
      "basis": "August TTM"
    },
    {
      "year": 2021,
      "roe": 0.30402893700787403,
      "basis": "August TTM"
    },
    {
      "year": 2022,
      "roe": 0.15778529076396808,
      "basis": "August TTM"
    },
    {
      "year": 2023,
      "roe": 0.18286565656565656,
      "basis": "August TTM"
    },
    {
      "year": 2024,
      "roe": 0.09594089347079039,
      "basis": "August TTM"
    },
    {
      "year": 2025,
      "roe": 0.044398009188361405,
      "basis": "August TTM"
    },
    {
      "year": 2026,
      "roe": 0.059496675191815854,
      "basis": "August TTM"
    }
  ],
  "roe_min": 0.044398009188361405,
  "channels": [
    "value"
  ],
  "proxy_candidate": false,
  "death_risk": "原研究风险摘录：三、最大的永久损失风险是负债，还是商业模式与现金转化退化？",
  "price_lines": {
    "watch": null,
    "good": null,
    "fat": null,
    "intrinsic_value": null,
    "basis": null,
    "condition": null,
    "currency": "CNY",
    "manual_gate": true
  },
  "current": {
    "price": null,
    "date": null,
    "pe": null,
    "dy": null,
    "market_cap": null,
    "source": null,
    "currency": "CNY",
    "source_count": 1
  },
  "buy_conditions": {
    "buy_when": null,
    "verify": null,
    "anchor": null,
    "source": null
  },
  "research_file": "research/300146.html",
  "research_document": {
    "code": "300146",
    "name": "汤臣倍健（汤臣倍健股份有限公司）",
    "guru": "李录·风险管理层",
    "business": "从事膳食营养补充剂业务，拥有汤臣倍健、健力多、lifespace等品牌，销售渠道覆盖药店、商超及线上电商；名称和主业经巨潮资讯2025年年报摘要确认。",
    "core_questions": [
      {
        "question": "一、管理层是否诚实面对错误，并把反思转化为经营结果？",
        "analysis": "【事实】2025年年报董事长信承认错失新周期开局和调整机会，明确表示渠道缺失等内部因素是主因；这是管理层自述，单源未交叉。2026年半年报则显示线上收入增长15.51%、线下下降4.85%，总营收增长3.94%，但归母利润下降18.11%、扣非下降19.74%。收入与利润已与证券之星公告摘要报道核对。【观点】公开承认战略误判，比完全归咎外部环境更值得肯定，线上增长也说明调整已有动作；反面是目前仍是收入恢复、盈利后退，不能把坦诚表达直接等同于执行能力。风险管理上应把管理层可信度拆成承认问题与改善资本回报两项，后者尚待验证，增长目标不能充当估值事实。来源：T1、T2、T3。"
      },
      {
        "question": "二、高分红和集中持股能否确保资本配置对小股东有利？",
        "analysis": "【事实】2025年年报摘要显示梁允超持股42.01%；按披露分红基数及每股0.45元预案计算，拟现金分红约占年度归母利润96.38%，这是预案计算而非本次核验的实际派发结果。年报全文披露期末商誉账面价值113629.17万元，并购和购买品牌形成的无形资产21394.86万元，相关数字单源未交叉。【观点】较高持股和现金回报可以强化利益绑定、约束无效扩张；反面是股权集中也提高决策依赖，而高支付率不能替代未来现金创造。商誉表明历史收购仍需持续盈利支撑，不能把账面权益全部视作可变现安全垫。应继续核查并购资产回报和重大投资审批，而不能仅凭股息率认定治理优秀。来源：T1、T4。"
      },
      {
        "question": "三、最大的永久损失风险是负债，还是商业模式与现金转化退化？",
        "analysis": "【事实】2026年上半年经营现金流1.784亿元，同比下降72.21%，同期归母利润6.031亿元，现金流与归母利润之比约0.296；巨潮摘要与证券之星一致。相较之下，2025年经营现金流12.137亿元，说明不能用去年的较好现金回收代替最新观察。上半年线上增长、线下下降进一步体现渠道迁移。【观点】当前最鲜明的风险是转型能否保持股东回报，而非已经证明的偿债危机。正面是收入恢复增长、品牌仍能产生利润；反面是增长伴随利润和现金转化走弱，可能使账面低估值变成价值陷阱。现金流下降的营运资本、税费及投放节奏尚未完整拆解，因此不指控利润失真，但在回款与复购改善前不能提高安全性评级。来源：T2、T3、T4。"
      }
    ],
    "score": "★★☆☆☆（2/5）",
    "conclusion": "管理层反思和股东回报态度有积极证据，但最新经营现金流及利润趋势削弱了安全边际；应以实际转型回报而非历史ROE、股息率或近净资产价格作为判断依据。",
    "findings": [
      "2026年上半年经营现金流同比下降72.21%，现金流/归母净利润约0.296，明显弱于用户面板所列1.552；两个指标期间可能不同，不能直接认定面板错误，但旧比率不足以代表最新经营质量。来源：T2巨潮半年报摘要 https://static.cninfo.com.cn/finalpage/2026-08-08/1225463645.PDF ；T3证券之星 https://stock.stockstar.com/RB2026080700041020.shtml 。数字跨平台核对，比值经计算。",
      "董事长公开承认错失渠道调整机会、内因是主，具备反思信号；但2026年上半年收入增长3.94%而扣非利润下降19.74%，执行效果仍未完成验证。来源：T1新浪年报全文 https://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=12009396&stockid=300146 ；T2、T3。管理层表述单源未交叉，财务数字已核对。",
      "2025年末商誉113629.17万元及并购品牌无形资产21394.86万元仍需未来现金流支撑；同期分红预案约占归母利润96.38%，高回报政策并不能自动消除资产减值风险。来源：T1；T4巨潮年报摘要 https://static.cninfo.com.cn/finalpage/2026-03-21/1225023314.PDF 。商誉及无形资产单源未交叉，支付率据预案与年报利润计算。"
    ],
    "verdict": "回避：在扣非利润、现金转化和渠道投入回报得到验证前，不以低PB和较高历史股息率作为买入理由。",
    "data_gaps": "已核查2025年及2026年半年报巨潮摘要，并检索新浪年报全文。尚缺半年报现金流变动完整桥接、维持性资本开支、最新商誉减值测试、分红实际实施核对、管理层激励考核与关联交易的完整审查；没有证据据此指控管理层失信。用户PB可能混用流通市值与全部归母权益，未确认日期和口径，不视为真实总市值PB。未创建或修改研究文件。"
  },
  "outside_watch": false,
  "triggers": [],
  "status": "watch",
  "provenance": {
    "research": "data/research/300146.json",
    "conditions": null,
    "quality": "尚未判级",
    "quote": null,
    "dupont": {
      "patch": "scripts/patch_v21_research.py",
      "method": "panel_residual_v1",
      "roe_date": "2026-08-31",
      "leverage_report_date": "2026-06-30"
    },
    "death_risk": {
      "source": "research_document",
      "field": "core_questions[2].question",
      "method": "原文风险句摘录，不新增研究观点"
    },
    "quality_classification": {
      "rule": "2026-10-02-rating-v2",
      "previous_tier": "unverified",
      "previous_in_pool": false
    }
  },
  "research_rating": 2,
  "data_quality": [
    "原始研究和行情保留单源声明；发现通道不等于质量认证",
    "价格到线只启动复核，不代表买入"
  ],
  "distance_pct": null,
  "quote_fresh": false,
  "triggered": false,
  "roe_discovery": false,
  "reject_reason_tags": [
    "渠道恶化",
    "利润成色",
    "估值口径",
    "现金转换"
  ],
  "reject_reason": "回避：在扣非利润、现金转化和渠道投入回报得到验证前，不以低PB和较高历史股息率作为买入理由。",
  "reject_reason_source": "companies.verdict（原研究判断摘录）",
  "tracking_state": "rejected",
  "verification_kind": "",
  "verification_reason": "",
  "tracking_kind": "",
  "tracking_checklist": [
    {
      "type": "人工",
      "item": "回避：在扣非利润、现金转化和渠道投入回报得到验证前，不以低PB和较高历史股息率作为买入理由。",
      "basis": "research_document.verdict（原研究摘录；未新增阈值）"
    }
  ],
  "monthly_review": {
    "month": "2026-10",
    "status": "本期未复核",
    "core_changes": "本期未复核",
    "reviewed_on": null,
    "event_count": null,
    "events": {},
    "sources": [],
    "decision": null,
    "observations": {},
    "source_file": "reports/monthly/2026-10.reviews.json"
  }
}